Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

JENBURKT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.005.966.836.735.38

What is the latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS is 9.00 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20259.00
Mar20245.96
Mar20236.83
Mar20226.73
Mar20215.38

How is EV/Core EBITDA of JENBURKT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 9
51.01
Mar2024 5.96
-12.74
Mar2023 6.83
1.49
Mar2022 6.73
25.09
Mar2021 5.38 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹445.7 Cr 0.6% 0.9% -1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

0.6%

0.9%

-1.9%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses